Patents by Inventor James Andrew Lumley

James Andrew Lumley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHEMICAL COMPOUNDS
    Publication number: 20110059043
    Abstract: The invention concerns benzodiazepine derivatives of Formula I: wherein W, X, L1, L2, L3, R1, R2, R3, R4, R5, R6 and R7 are as defined in the description. The present invention also relates to processes for the preparation of such compounds, pharmaceutical compositions containing them and their use in the treatment or prophylaxis of hepatitis C virus infection.
    Type: Application
    Filed: September 2, 2010
    Publication date: March 10, 2011
    Applicant: ARROW THERAPEUTICS LIMITED
    Inventors: Michael Christopher Stratton BARNES, Helena Jade DENNISON, Stephen Sean FLACK, James Andrew LUMLEY, Pui Shan PANG, Keith Charles SPENCER
  • NOVEL COMPOUNDS 660
    Publication number: 20100278835
    Abstract: The invention provides compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are as defined in the specification, and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are useful in the treatment of respiratory syncytial virus (RSV).
    Type: Application
    Filed: March 9, 2010
    Publication date: November 4, 2010
    Applicants: ASTRAZENECA UK LIMITED, ARROW THERAPEUTICS LIMITED
    Inventors: Helen Blade, Heather Marie Jackson, Gary Peter Tomkinson, Elisa Ann Carron, James Andrew Lumley, Christopher John Pilkington, Alexander James Floyd Thomas, Justin Warne